US20060161245A1 - Interlocking endoluminal device - Google Patents

Interlocking endoluminal device Download PDF

Info

Publication number
US20060161245A1
US20060161245A1 US11/385,621 US38562106A US2006161245A1 US 20060161245 A1 US20060161245 A1 US 20060161245A1 US 38562106 A US38562106 A US 38562106A US 2006161245 A1 US2006161245 A1 US 2006161245A1
Authority
US
United States
Prior art keywords
outer member
fluid
inner member
stent
opening
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US11/385,621
Inventor
Ronald Rakos
Krzysztof Sowinski
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Lifeshield Sciences LLC
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to US11/385,621 priority Critical patent/US20060161245A1/en
Publication of US20060161245A1 publication Critical patent/US20060161245A1/en
Assigned to ACACIA RESEARCH GROUP LLC reassignment ACACIA RESEARCH GROUP LLC ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: BOSTON SCIENTIFIC SCIMED, INC.
Assigned to LIFESHIELD SCIENCES LLC reassignment LIFESHIELD SCIENCES LLC ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: ACACIA RESEARCH GROUP LLC
Abandoned legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/04Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
    • A61F2/06Blood vessels
    • A61F2/07Stent-grafts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/04Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
    • A61F2/06Blood vessels
    • A61F2002/065Y-shaped blood vessels
    • A61F2002/067Y-shaped blood vessels modular

Definitions

  • This invention relates generally to endoluminal devices and, more specifically, to endoluminal devices such as stents, grafts, and stent-grafts.
  • a stent is an elongated device used to support an intraluminal wall.
  • a stent provides an unobstructed conduit through a body lumen in the area of the stenosis.
  • Such a stent may also have a prosthetic graft layer of fabric or covering lining the inside and/or outside thereof.
  • Such a covered stent is commonly referred to in the art as an intraluminal prosthesis, an endoluminal or endovascular graft (EVG), or a stent-graft.
  • EVG endoluminal or endovascular graft
  • the term “stent” is a shorthand reference referring to a covered or uncovered such device.
  • a covered stent may be used, for example, to treat a vascular aneurysm by removing the pressure on a weakened part of an artery so as to reduce the risk of rupture.
  • a stent is implanted in a blood vessel at the site of a stenosis or aneurysm endoluminally, i.e. by so-called “minimally invasive techniques” in which the stent, restrained in a radially compressed configuration by a sheath or catheter, is delivered by a stent delivery system or “introducer” to the site where it is required.
  • the introducer may enter the body from an access location outside the body, such as through the patient's skin, or by a “cut down” technique in which the entry blood vessel is exposed by minor surgical means.
  • proximal refers to portions of the stent or delivery system relatively closer to this access location, whereas the term “distal” is used to refer to portions farther from the access location.
  • the introducer When the introducer has been threaded into the body lumen to the stent deployment location, the introducer is manipulated to cause the stent to be ejected from the surrounding sheath or catheter in which it is restrained (or alternatively the surrounding sheath or catheter is retracted from the stent), whereupon the stent expands to a predetermined diameter at the deployment location, and the introducer is withdrawn.
  • Stent expansion may be effected by spring elasticity, balloon expansion, or by the self-expansion of a thermally or stress-induced return of a memory material to a pre-conditioned expanded configuration.
  • stent-grafts are for deployment in branching lumen, and more specifically for bifurcated lumen, such as for repair of abdominal aortic aneurysms (AAA).
  • AAA abdominal aortic aneurysms
  • Various stent-graft configurations are known in the art for bifurcated applications, including single-piece (“unitary”) designs and modular designs.
  • Bifurcated devices may involve special tooling and procedures for their manufacture that result in high cycle time and low yields, may utilize relatively large-profile delivery systems or specialized delivery systems, and in general may be relatively complex in design and implementation. Modular devices typically also have a risk of leaks in the seals between the modular components.
  • a modular endoluminal device such as a bifurcated stent-graft, that accommodates a branching flow path yet minimizes drawbacks often associated with bifurcated and/or modular devices.
  • an endoluminal device comprising a first member and a second member.
  • the first member comprises a first trunk portion, a first midsection comprising a first opening, and a first leg portion.
  • the second member comprises a second trunk portion, a second midsection comprising a second opening, and a second leg portion.
  • the device has an assembled configuration in which the first member and second member are interlocked with one another with the second trunk portion coaxially contained within the first trunk portion, the second leg portion protruding through the first opening, and the second opening facing the first leg portion.
  • the second midsection may further comprise a leg stump portion that protrudes into the first leg portion of the first member in the assembled configuration.
  • the first member and the second member each may further comprise a stent having a covering inside, outside, or inside and outside of the stent.
  • the covering may comprise a textile, a plastic, or a combination thereof.
  • the first member may comprise an uncovered portion of the stent, such as an uncovered portion adapted to be located at an intersection of a renal lumen with the aorta.
  • the first member may comprise a partial inside covering and the second member may comprise an outside covering, where the first member has no inside covering in an interlocking portion adapted to contact the outside covering of the second member.
  • the invention also comprises a modular endoluminal device for deployment in a body lumen comprising a main lumen, a first branch lumen, a second branch lumen, and an internal fluid flowing in a first direction from the main lumen into the first and second branch lumens.
  • the device comprises a first member for directing the fluid from the main lumen into the first branch lumen and a second member for directing the fluid from the main lumen into the second branch lumen.
  • the device therefore, accommodates a branching fluid flow.
  • the first member and the second member are adapted to interlock together such that the fluid flow forces the second member against the first member in a sealing relationship.
  • the second member may comprise at least one impingement area on which the fluid flow impinges to force the second member against the first member.
  • a system for deployment of an endoluminal device of this invention may comprise a first introducer for deploying the first member into a body lumen and having a first profile; and a second introducer, having a second profile essentially identical to the first profile, for deploying the second member into the body lumen.
  • the invention also comprises a method of deploying an endoluminal device of the present invention in a deployment location in a branched lumen comprising a main lumen, a first branch lumen, and a second branch lumen.
  • the method comprises the steps of inserting a first introducer containing the first member into the branched lumen from a first proximal location, and deploying the first member with the first trunk portion in the main lumen and the first leg portion in the first branch lumen.
  • a second introducer containing the second member is then inserted into the branched lumen from a second proximal location and the second member is deployed such that the second member is interlocked with the first member in the assembled configuration with the second trunk portion coaxially contained within the first trunk portion, the second leg portion protruding through the first opening into the second branch lumen, and the second opening facing the first leg portion.
  • FIG. 1 is a plan view illustration showing an exemplary embodiment of a device of the present invention
  • FIG. 2 is a longitudinal section view showing another exemplary embodiment of a device of the present invention.
  • FIG. 3 is a cross-sectional illustration of a portion of an exemplary wall taken across line 3 - 3 in FIG. 1 ;
  • FIG. 4 is a plan view illustration of an exemplary tapered member of the present invention.
  • FIG. 5 is a plan view illustration of an exemplary member of the present invention having a straight leg design.
  • Device 10 may be said to be “modular” in that it is constructed of more than one standardized, although not necessarily identical, units.
  • device 10 comprises two members 12 and 22 .
  • First member 12 comprises a first trunk portion 14 , a first midsection 16 comprising a first opening 17 , and a first leg portion 18 .
  • Second member 22 comprises a second trunk portion 24 , a second midsection 26 comprising a second opening 27 , and a second leg portion 28 .
  • First member 12 and second member 22 are adapted to interlock with one another in an assembled configuration in which second trunk portion 24 is coaxially contained within first trunk portion 14 , second leg portion 28 protrudes through the first opening 17 , and second opening 27 faces first leg portion 18 .
  • First opening 17 may have a greater area than the second opening 27 .
  • the shape of first opening 17 may generally be the shape of the outer periphery of the portion of second member 22 which extends through the opening.
  • the shape of second opening 27 may generally be suitable to be an extension of the flow path defined by first member 12 .
  • Endoluminal device 100 also comprises first and second members 112 and 122 , each having respective trunk portions 14 and 24 , midsections 16 and 26 , openings 17 and 27 , and leg portions 18 and 28 , similar to members 12 and 22 .
  • Second midsection 26 of second modular member 122 further comprises a leg stump portion 30 opposite leg portion 28 .
  • Leg stump portion 30 has an open end 32 comprising opening 27 .
  • Leg stump portion 30 is adapted to protrude into the first leg portion 18 when first member 112 and second member 122 are interlocked.
  • Leg stump portion 30 serves to further stabilize second member 122 within first member 112 , and may extend into leg portion 18 any suitable length.
  • Device 100 shown in FIG. 2 further comprises a seal ring 40 in trunk portion 14 of first member 112 .
  • Seal ring 40 may comprise any circumferential area of the device having greater sealing properties than the surrounding areas of the device.
  • device 100 may comprise a stent that exerts a certain radial force per unit length throughout the stent, but the seal ring portion exerts a greater radial force.
  • the stent may have a covering comprising one type of material over much of the stent surface area and a different material in the area of the seal ring.
  • the material in the seal ring may comprise a knit material with a heavier texture than the surrounding material.
  • the greater sealing properties of the underlying stent may result from the use of a first stent pattern, such as a woven mesh with a first amount of open area between filaments, in the area surrounding the seal ring, and a second stent pattern, such as a more densely woven mesh with a second, lesser amount of open area between filaments, in the seal ring itself.
  • a first stent pattern such as a woven mesh with a first amount of open area between filaments, in the area surrounding the seal ring
  • a second stent pattern such as a more densely woven mesh with a second, lesser amount of open area between filaments, in the seal ring itself.
  • seal rings may be located anywhere along the body of the first or second member where desired. For example, seal rings may be particularly useful at the distal or proximal ends of the members for sealing against the lumen wall, as illustrated by seal ring 40 . Seal rings may also be useful in the first member opening 17 or on the corresponding portion of second member 22 or 122 that is contacted by opening 17 , to facilitate a stronger seal at the interface between the first and second members.
  • the respective members of endoluminal devices 10 and 100 may comprise a stent 42 having at least a partial covering 44 inside, outside, or inside and outside of the stent.
  • the stent itself may be any type of stent known in the art, such as a filamentary stent or a stent fabricated by laser or otherwise cutting a preformed tube or sheet to be rolled into a tube.
  • the stent may also comprise any stent material known in the art, such as a plastically deformable material such as stainless steel, or a superelastic material or shape-memory material, such as nitinol, or some combination thereof. Accordingly, the stent may be balloon expandable, self-expanding, or some combination thereof.
  • the stent construction is not limited, however, to any particular design, architecture, fabrication method, deployment method, or materials.
  • Covering 44 may comprise a textile, such as a knit or woven textile, a plastic, such as ePTFE or urethane, or a combination thereof.
  • a textile such as a knit or woven textile
  • plastic such as ePTFE or urethane
  • FIG. 3 there is shown a cross-section of an exemplary device taken across line 3 - 3 in FIG. 1 , with the inner surface of the device at the bottom and the outer surface of the device at the top.
  • the device may comprise a stent 42 have both an outside ePTFE covering 50 and an inside ePTFE covering 52 .
  • the outside ePTFE covering 50 may further comprise a textile covering 54 , such as a knit or woven covering as shown in FIG. 3 .
  • the textile covering may, for example, comprise stretchable PET or polyester yarn.
  • the stent may have no inner ePTFE covering 52 or no outer textile covering 54 . Any combination of the coverings, however, may be present.
  • first member 112 may comprise an inside covering 52 and second member 122 may comprise an outside covering 50 .
  • first member 112 of device 100 may further comprise an uncovered portion 56 of stent 42 .
  • Uncovered portion 56 of stent 42 may comprise a hexagonal cell design, wherein each cell 46 typically has a pointed apex section 48 at opposite ends, or any design known in the art.
  • cells 46 are end cells that have pointed apex sections 48 at the proximal end and flat distal ends 47 , providing pentagons rather than hexagons.
  • the covered portion of stent 42 may comprise the same geometric pattern or a different pattern as the end geometry.
  • uncovered portion 56 may be located at an intersection of branch lumens 71 A and 71 B, such as the intersection of the renal arteries with the aorta.
  • branch lumens 71 A and 71 B such as the intersection of the renal arteries with the aorta.
  • second trunk portion 24 of second member 122 is not distally coextensive with first trunk portion 14 of first member 112 . That is, first trunk portion 14 comprises the uncovered portion 56 which extends further distally than trunk portion 24 . In other designs, however, the two trunk portions may end at the same distal location.
  • each member 12 and 22 has a tapered diameter throughout its entire length, tapering from a larger diameter at the distal end to a smaller diameter at the proximal end.
  • at least the leg portions may have a constant diameter, as shown in FIG. 2 .
  • the overall member design may differ for a tapering leg design as compared to a straight leg design.
  • FIGS. 4 and 5 there are shown a first member 212 with a tapered leg design and a first member 312 with a straight leg design, respectively.
  • Opening 217 in tapered-leg first member 212 has essentially an tear-drop or egg shape, and the body of first member 212 has a smooth curvature.
  • Opening 317 in straight-leg first member 312 has an almost triangular projection, whereas the body of first member 312 comprises three distinct sections, a larger diameter trunk portion 314 , a tapered midsection 316 , and a smaller diameter leg portion 318 .
  • any endoluminal device typically has a compressed configuration and an expanded configuration, and each device has a respective diameter or profile in each configuration.
  • the individual modular members may differ in compressed profile significantly enough that differently sized delivery systems may be required to deploy each member.
  • the term “profile” refers to the largest diameter of any portion of a device in a compressed configuration. For the design shown in FIG. 1 , however, each of the modular members has a similar, if not identical, compressed profile, and can thus be introduced into the body using similarly sized delivery systems.
  • each member 12 and 22 comprises only a trunk section and a single leg
  • the delivery system may be relatively smaller than a delivery system designed to deploy a bifurcated device having a trunk section and at least a portion of two legs.
  • Members 12 and 22 do not have a profile any larger than any non-branching device having a diameter the size of the diameter of trunk portion 14 , and thus do not require a delivery system any larger than for such a non-branching device.
  • first member 12 and second member 22 also means that they can be constructed using similar tooling, and the simplicity of both means that they can be constructed without the need for any of the special or complex tooling typically required for bifurcated systems.
  • the simplicity of design also makes the members relatively easier to cover using existing lamination and bonding techniques, resulting in reduced cycle time and higher yields as compared to traditional bifurcated devices.
  • the device is typically deployed in a body lumen comprising a main lumen 70 , a first branch lumen 72 , a second branch lumen 74 , and an internal fluid 76 flowing in a first direction along arrow A from the main lumen into the first and second branch lumens.
  • First member 112 directs fluid 76 from main lumen 70 into first branch lumen 72 and second member 22 directs the fluid from the main lumen into second branch lumen 74 .
  • the shear force of fluid 76 flowing in the direction of arrow A tends to force second member 22 against first member 12 in a sealing relationship.
  • the fluid pressure wedges second member 22 further into opening 17 of member 12 , strengthening the seal between opening 17 and the member 22 .
  • fluid 76 impinges against inner crotch 78 in second member 122 and adds to the force that interlocks members 112 and 122 together.
  • a design without a leg stump 30 such as the design shown in FIG. 1 , there is a sharper transition between the midsection and the legs that may provide more advantageous hemodynamics because there is no dead space where clots can form.
  • the endoluminal device of the present invention may be introduced by any known surgical procedure.
  • the device is introduced endoluminally, by first introducing first member 12 to its location, in a proper radial orientation using radiopaque markers such that first opening faces second branch lumen 74 (as shown in FIG. 2 ).
  • second member 22 is deployed by directing a second introducer through first opening 17 .
  • second member 22 can be deployed directly to its ultimate location to be desired.
  • the deployed device may be inspected using fluoroscopy, optionally following injection of a contrast media, as is known in the art, to ascertain that the second member 122 has seated properly in abutment with first member 112 .
  • mechanical means such as but not limited to a hook or tethers attached to the second member, may be used to adjust the position of second member 122 .
  • the stent may be deployed by any type of expansion known in the art. Regardless of how the stent is initially deployed, balloon devices may be used to model the members into place to conform to the topography of the lumen, as is known in the art.
  • First member 112 may be introduced from a proximal location downstream of the deployment location through first branch lumen 72 , and second member 122 introduced from a proximal location through branch lumen 74 , or one or both members may be introduced through main lumen 70 from proximal locations upstream of the deployment location.

Abstract

An endoluminal device comprises at least a first member and a second member, which may be modular. The first member comprises a first trunk portion, a first midsection comprising a first opening, and a first leg portion. The second member comprises a second trunk portion, a second midsection comprising a second opening, and a second leg portion. The device has an assembled configuration in which the first member and second member are interlocked with one another with the second trunk portion coaxially contained within the first trunk portion, the second leg portion protruding through the first opening, and the second opening facing the first leg portion. The second midsection may have a leg stump portion that protrudes into the first leg portion of the first member in the assembled configuration. A system and method for deploying the device may use identical catheters for deploying the two members.

Description

    CROSS REFERENCE TO RELATED APPLICATIONS
  • This application is a continuation of U.S. patent application Ser. No. 10/010,628, filed Nov. 7, 2001, the contents of which are incorporated herein by reference.
  • TECHNICAL FIELD
  • This invention relates generally to endoluminal devices and, more specifically, to endoluminal devices such as stents, grafts, and stent-grafts.
  • BACKGROUND OF THE INVENTION
  • A stent is an elongated device used to support an intraluminal wall. In the case of a stenosis, a stent provides an unobstructed conduit through a body lumen in the area of the stenosis. Such a stent may also have a prosthetic graft layer of fabric or covering lining the inside and/or outside thereof. Such a covered stent is commonly referred to in the art as an intraluminal prosthesis, an endoluminal or endovascular graft (EVG), or a stent-graft. As used herein, however, the term “stent” is a shorthand reference referring to a covered or uncovered such device.
  • A covered stent may be used, for example, to treat a vascular aneurysm by removing the pressure on a weakened part of an artery so as to reduce the risk of rupture. Typically, a stent is implanted in a blood vessel at the site of a stenosis or aneurysm endoluminally, i.e. by so-called “minimally invasive techniques” in which the stent, restrained in a radially compressed configuration by a sheath or catheter, is delivered by a stent delivery system or “introducer” to the site where it is required. The introducer may enter the body from an access location outside the body, such as through the patient's skin, or by a “cut down” technique in which the entry blood vessel is exposed by minor surgical means. The term “proximal” as used herein refers to portions of the stent or delivery system relatively closer to this access location, whereas the term “distal” is used to refer to portions farther from the access location.
  • When the introducer has been threaded into the body lumen to the stent deployment location, the introducer is manipulated to cause the stent to be ejected from the surrounding sheath or catheter in which it is restrained (or alternatively the surrounding sheath or catheter is retracted from the stent), whereupon the stent expands to a predetermined diameter at the deployment location, and the introducer is withdrawn. Stent expansion may be effected by spring elasticity, balloon expansion, or by the self-expansion of a thermally or stress-induced return of a memory material to a pre-conditioned expanded configuration.
  • Among the many applications for stent-grafts is for deployment in branching lumen, and more specifically for bifurcated lumen, such as for repair of abdominal aortic aneurysms (AAA). Various stent-graft configurations are known in the art for bifurcated applications, including single-piece (“unitary”) designs and modular designs. Bifurcated devices, however, may involve special tooling and procedures for their manufacture that result in high cycle time and low yields, may utilize relatively large-profile delivery systems or specialized delivery systems, and in general may be relatively complex in design and implementation. Modular devices typically also have a risk of leaks in the seals between the modular components. Thus, it is desirable to provide a modular endoluminal device, such as a bifurcated stent-graft, that accommodates a branching flow path yet minimizes drawbacks often associated with bifurcated and/or modular devices.
  • SUMMARY OF THE INVENTION
  • In accordance with this invention, there is provided an endoluminal device comprising a first member and a second member. The first member comprises a first trunk portion, a first midsection comprising a first opening, and a first leg portion. The second member comprises a second trunk portion, a second midsection comprising a second opening, and a second leg portion. The device has an assembled configuration in which the first member and second member are interlocked with one another with the second trunk portion coaxially contained within the first trunk portion, the second leg portion protruding through the first opening, and the second opening facing the first leg portion. The second midsection may further comprise a leg stump portion that protrudes into the first leg portion of the first member in the assembled configuration.
  • The first member and the second member each may further comprise a stent having a covering inside, outside, or inside and outside of the stent. The covering may comprise a textile, a plastic, or a combination thereof. The first member may comprise an uncovered portion of the stent, such as an uncovered portion adapted to be located at an intersection of a renal lumen with the aorta. The first member may comprise a partial inside covering and the second member may comprise an outside covering, where the first member has no inside covering in an interlocking portion adapted to contact the outside covering of the second member.
  • The invention also comprises a modular endoluminal device for deployment in a body lumen comprising a main lumen, a first branch lumen, a second branch lumen, and an internal fluid flowing in a first direction from the main lumen into the first and second branch lumens. The device comprises a first member for directing the fluid from the main lumen into the first branch lumen and a second member for directing the fluid from the main lumen into the second branch lumen. The device, therefore, accommodates a branching fluid flow. The first member and the second member are adapted to interlock together such that the fluid flow forces the second member against the first member in a sealing relationship. The second member may comprise at least one impingement area on which the fluid flow impinges to force the second member against the first member.
  • A system for deployment of an endoluminal device of this invention may comprise a first introducer for deploying the first member into a body lumen and having a first profile; and a second introducer, having a second profile essentially identical to the first profile, for deploying the second member into the body lumen.
  • The invention also comprises a method of deploying an endoluminal device of the present invention in a deployment location in a branched lumen comprising a main lumen, a first branch lumen, and a second branch lumen. The method comprises the steps of inserting a first introducer containing the first member into the branched lumen from a first proximal location, and deploying the first member with the first trunk portion in the main lumen and the first leg portion in the first branch lumen. A second introducer containing the second member is then inserted into the branched lumen from a second proximal location and the second member is deployed such that the second member is interlocked with the first member in the assembled configuration with the second trunk portion coaxially contained within the first trunk portion, the second leg portion protruding through the first opening into the second branch lumen, and the second opening facing the first leg portion.
  • It is to be understood that both the foregoing general description and the following detailed description are exemplary, but not restrictive, of the invention.
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • The invention is best understood from the following detailed description when read in connection with the accompanying drawing, in which:
  • FIG. 1 is a plan view illustration showing an exemplary embodiment of a device of the present invention;
  • FIG. 2 is a longitudinal section view showing another exemplary embodiment of a device of the present invention;
  • FIG. 3 is a cross-sectional illustration of a portion of an exemplary wall taken across line 3-3 in FIG. 1;
  • FIG. 4 is a plan view illustration of an exemplary tapered member of the present invention; and
  • FIG. 5 is a plan view illustration of an exemplary member of the present invention having a straight leg design.
  • DETAILED DESCRIPTION OF THE INVENTION
  • The invention will next be illustrated with reference to the figures wherein the same numbers indicate similar elements in all figures. Such figures are intended to be illustrative rather than limiting and are included herewith to facilitate the explanation of the apparatus of the present invention.
  • Referring now to FIG. 1, there is shown an exemplary endoluminal device 10 of this invention. Device 10 may be said to be “modular” in that it is constructed of more than one standardized, although not necessarily identical, units. In particular, device 10 comprises two members 12 and 22. First member 12 comprises a first trunk portion 14, a first midsection 16 comprising a first opening 17, and a first leg portion 18. Second member 22 comprises a second trunk portion 24, a second midsection 26 comprising a second opening 27, and a second leg portion 28. First member 12 and second member 22 are adapted to interlock with one another in an assembled configuration in which second trunk portion 24 is coaxially contained within first trunk portion 14, second leg portion 28 protrudes through the first opening 17, and second opening 27 faces first leg portion 18. First opening 17 may have a greater area than the second opening 27. The shape of first opening 17 may generally be the shape of the outer periphery of the portion of second member 22 which extends through the opening. The shape of second opening 27 may generally be suitable to be an extension of the flow path defined by first member 12.
  • Referring now to FIG. 2, there is shown another exemplary endoluminal device 100. Endoluminal device 100 also comprises first and second members 112 and 122, each having respective trunk portions 14 and 24, midsections 16 and 26, openings 17 and 27, and leg portions 18 and 28, similar to members 12 and 22. Second midsection 26 of second modular member 122, however, further comprises a leg stump portion 30 opposite leg portion 28. Leg stump portion 30 has an open end 32 comprising opening 27. Leg stump portion 30 is adapted to protrude into the first leg portion 18 when first member 112 and second member 122 are interlocked. Leg stump portion 30 serves to further stabilize second member 122 within first member 112, and may extend into leg portion 18 any suitable length.
  • Device 100 shown in FIG. 2 further comprises a seal ring 40 in trunk portion 14 of first member 112. Seal ring 40 may comprise any circumferential area of the device having greater sealing properties than the surrounding areas of the device. For example, device 100 may comprise a stent that exerts a certain radial force per unit length throughout the stent, but the seal ring portion exerts a greater radial force. Alternatively, the stent may have a covering comprising one type of material over much of the stent surface area and a different material in the area of the seal ring. For example, the material in the seal ring may comprise a knit material with a heavier texture than the surrounding material. The greater sealing properties of the underlying stent may result from the use of a first stent pattern, such as a woven mesh with a first amount of open area between filaments, in the area surrounding the seal ring, and a second stent pattern, such as a more densely woven mesh with a second, lesser amount of open area between filaments, in the seal ring itself. Other embodiments of seal rings suitable for use in this invention are disclosed in U.S. patent application Ser. No. 09/898,936 entitled IMPLANT HAVING IMPROVED FIXATION TO A BODY LUMEN AND METHOD FOR IMPLANTING THE SAME by Paul DiCarlo and filed on Jul. 3, 2001, incorporated herein by reference. Any seal ring embodiment may be used, however, such as but not limited to embodiments described in U.S. Pat. No. 5,575,818 to Pinchuk, incorporated herein by reference. Seal rings may be located anywhere along the body of the first or second member where desired. For example, seal rings may be particularly useful at the distal or proximal ends of the members for sealing against the lumen wall, as illustrated by seal ring 40. Seal rings may also be useful in the first member opening 17 or on the corresponding portion of second member 22 or 122 that is contacted by opening 17, to facilitate a stronger seal at the interface between the first and second members.
  • The respective members of endoluminal devices 10 and 100 may comprise a stent 42 having at least a partial covering 44 inside, outside, or inside and outside of the stent. The stent itself may be any type of stent known in the art, such as a filamentary stent or a stent fabricated by laser or otherwise cutting a preformed tube or sheet to be rolled into a tube. The stent may also comprise any stent material known in the art, such as a plastically deformable material such as stainless steel, or a superelastic material or shape-memory material, such as nitinol, or some combination thereof. Accordingly, the stent may be balloon expandable, self-expanding, or some combination thereof. The stent construction is not limited, however, to any particular design, architecture, fabrication method, deployment method, or materials.
  • Covering 44 may comprise a textile, such as a knit or woven textile, a plastic, such as ePTFE or urethane, or a combination thereof. Referring now to FIG. 3, there is shown a cross-section of an exemplary device taken across line 3-3 in FIG. 1, with the inner surface of the device at the bottom and the outer surface of the device at the top. As shown in FIG. 3, the device may comprise a stent 42 have both an outside ePTFE covering 50 and an inside ePTFE covering 52. The outside ePTFE covering 50 may further comprise a textile covering 54, such as a knit or woven covering as shown in FIG. 3. The textile covering may, for example, comprise stretchable PET or polyester yarn. In an alternative embodiment, the stent may have no inner ePTFE covering 52 or no outer textile covering 54. Any combination of the coverings, however, may be present.
  • The covering configuration may be the same throughout each member, or may vary in different areas according to need. For example, first member 112 may comprise an inside covering 52 and second member 122 may comprise an outside covering 50. The interlocking portion 60 of first member 12 that is adapted to contact the outside covering of the second member, however, may have no inside covering.
  • As shown in FIG. 2, first member 112 of device 100 may further comprise an uncovered portion 56 of stent 42. Uncovered portion 56 of stent 42 may comprise a hexagonal cell design, wherein each cell 46 typically has a pointed apex section 48 at opposite ends, or any design known in the art. As shown in FIG. 2, cells 46 are end cells that have pointed apex sections 48 at the proximal end and flat distal ends 47, providing pentagons rather than hexagons. The covered portion of stent 42 may comprise the same geometric pattern or a different pattern as the end geometry. For endoluminal device 100, which is shown mounted in a branched lumen, such as the aorta, uncovered portion 56 may be located at an intersection of branch lumens 71A and 71B, such as the intersection of the renal arteries with the aorta. Such a configuration prevents the stent covering from blocking blood flow to the branch arteries. Thus, as shown in FIG. 2, second trunk portion 24 of second member 122 is not distally coextensive with first trunk portion 14 of first member 112. That is, first trunk portion 14 comprises the uncovered portion 56 which extends further distally than trunk portion 24. In other designs, however, the two trunk portions may end at the same distal location.
  • As shown in FIG. 1, each member 12 and 22 has a tapered diameter throughout its entire length, tapering from a larger diameter at the distal end to a smaller diameter at the proximal end. In other designs, however, at least the leg portions may have a constant diameter, as shown in FIG. 2. The overall member design may differ for a tapering leg design as compared to a straight leg design. For example, referring now to FIGS. 4 and 5, there are shown a first member 212 with a tapered leg design and a first member 312 with a straight leg design, respectively. Opening 217 in tapered-leg first member 212 has essentially an tear-drop or egg shape, and the body of first member 212 has a smooth curvature. Opening 317 in straight-leg first member 312 has an almost triangular projection, whereas the body of first member 312 comprises three distinct sections, a larger diameter trunk portion 314, a tapered midsection 316, and a smaller diameter leg portion 318.
  • One advantage of the present invention is that the modular components may be similar in size and profile. For example, any endoluminal device typically has a compressed configuration and an expanded configuration, and each device has a respective diameter or profile in each configuration. For many bifurcated modular devices known in the art, the individual modular members may differ in compressed profile significantly enough that differently sized delivery systems may be required to deploy each member. As used herein, the term “profile” refers to the largest diameter of any portion of a device in a compressed configuration. For the design shown in FIG. 1, however, each of the modular members has a similar, if not identical, compressed profile, and can thus be introduced into the body using similarly sized delivery systems. Furthermore, because each member 12 and 22 comprises only a trunk section and a single leg, the delivery system may be relatively smaller than a delivery system designed to deploy a bifurcated device having a trunk section and at least a portion of two legs. Members 12 and 22 do not have a profile any larger than any non-branching device having a diameter the size of the diameter of trunk portion 14, and thus do not require a delivery system any larger than for such a non-branching device.
  • The similarity in profile and geometry of first member 12 and second member 22 also means that they can be constructed using similar tooling, and the simplicity of both means that they can be constructed without the need for any of the special or complex tooling typically required for bifurcated systems. The simplicity of design also makes the members relatively easier to cover using existing lamination and bonding techniques, resulting in reduced cycle time and higher yields as compared to traditional bifurcated devices.
  • The interlocking design of the device of this invention also provides certain advantages. As shown in FIG. 2, the device is typically deployed in a body lumen comprising a main lumen 70, a first branch lumen 72, a second branch lumen 74, and an internal fluid 76 flowing in a first direction along arrow A from the main lumen into the first and second branch lumens. First member 112 directs fluid 76 from main lumen 70 into first branch lumen 72 and second member 22 directs the fluid from the main lumen into second branch lumen 74. The shear force of fluid 76 flowing in the direction of arrow A tends to force second member 22 against first member 12 in a sealing relationship. That is, the fluid pressure wedges second member 22 further into opening 17 of member 12, strengthening the seal between opening 17 and the member 22. In particular, fluid 76 impinges against inner crotch 78 in second member 122 and adds to the force that interlocks members 112 and 122 together. In a design without a leg stump 30, such as the design shown in FIG. 1, there is a sharper transition between the midsection and the legs that may provide more advantageous hemodynamics because there is no dead space where clots can form.
  • The endoluminal device of the present invention may be introduced by any known surgical procedure. Preferably, the device is introduced endoluminally, by first introducing first member 12 to its location, in a proper radial orientation using radiopaque markers such that first opening faces second branch lumen 74 (as shown in FIG. 2). Then, second member 22 is deployed by directing a second introducer through first opening 17. In the embodiment shown in FIG. 1, second member 22 can be deployed directly to its ultimate location to be desired. In the embodiment shown in FIG. 2, however, it is desirable to initially deploy second member 122 at a location slightly upstream of its ultimate resting place to ensure that leg stump 30 leads to first branch lumen 32. Endoluminal fluid flow in the direction of arrow A may then move second member 122 proximally until crotch 78 of second member 122 abuts first member 112.
  • The deployed device may be inspected using fluoroscopy, optionally following injection of a contrast media, as is known in the art, to ascertain that the second member 122 has seated properly in abutment with first member 112. If necessary, mechanical means, such as but not limited to a hook or tethers attached to the second member, may be used to adjust the position of second member 122. As noted above, the stent may be deployed by any type of expansion known in the art. Regardless of how the stent is initially deployed, balloon devices may be used to model the members into place to conform to the topography of the lumen, as is known in the art.
  • First member 112 may be introduced from a proximal location downstream of the deployment location through first branch lumen 72, and second member 122 introduced from a proximal location through branch lumen 74, or one or both members may be introduced through main lumen 70 from proximal locations upstream of the deployment location.
  • Furthermore, although illustrated and described herein with reference to certain specific embodiments, the present invention is nevertheless not intended to be limited to the details shown. Rather, various modifications may be made in the details within the scope and range of equivalents of the claims and without departing from the spirit of the invention.

Claims (14)

1. A modular endoluminal device comprising an outer member and an inner member, the outer member and inner member each comprising a stent-graft, a fluid inlet opening, a first fluid exit opening, and a second fluid exit opening, the device having an assembled configuration in which the inner member fits partially inside the outer member and partially protrudes through the outer member first exit opening such that the inner member inlet opening aligns with the outer member inlet opening and the inner member first exit opening aligns with the outer member second exit opening, the device adapted to receive a fluid stream through the aligned inner and outer member inlet openings and to discharge the fluid from the device in two discharge streams, one through each of the second fluid exit openings.
2. The endoluminal device of claim 1, wherein the outer member further comprises a seal ring.
3. The endoluminal device of claim 2, wherein the seal ring is positioned adjacent the fluid inlet opening.
4. The endoluminal device of claim 2, wherein the seal ring is positioned adjacent the first fluid exit opening.
5. The endoluminal device of claim 1, wherein at least one stent-graft comprises a textile, a plastic, or a combination thereof.
6. The endoluminal device of claim 1, wherein the device is adapted to be mounted in an aorta and the stent-graft comprises an uncovered stent portion positioned to be located at an intersection of a renal lumen with the aorta.
7. The endoluminal device of claim 6, wherein the uncovered stent portion comprises a hexagonal cell design.
8. The endoluminal device of claim 1, wherein each of the inner member and the outer member has a tapered diameter.
9. The endoluminal device of claim 1, wherein the fluid inlet opening is located at a distal end of each member, and the fluid inlet opening of the inner member is positioned proximal the fluid inlet opening of the outer member in the assembled configuration.
10. The endoluminal device of claim 1, wherein the fluid inlet opening is located at a distal end of each member, and the fluid inlet opening of the inner member is distally coextensive with the fluid inlet opening of the outer member in the assembled configuration.
11. The device of claim 1, wherein each of the inner member and the outer member comprises an inside surface and an outside surface, the inner member further comprising at least one impingement area positioned receive fluid flow to force the outside surface of the inner member against the inside surface of the outer member in the assembled configuration.
12. The endoluminal device of claim 1 wherein the inner member further comprises a leg stump portion leading to the first fluid exit opening, the outer member further comprises a leg portion leading to the second fluid exit, and the leg stump portion protrudes into the leg portion in the assembled configuration.
13. A two-component, bifurcated endoluminal device kit comprising:
a first stent-graft component comprising a trunk portion, a first long leg portion connected to the trunk portion and a short leg portion connected to the trunk portion adjacent the long leg portion; and
a second stent-graft component comprising a trunk portion, a second long leg portion for receiving the short leg, and a long leg receiving aperture;
wherein the first long leg is adapted to be inserted through the long leg receiving aperture, and the short leg is adapted to be inserted into the second long leg, thereby forming a bifurcated endoluminal device.
14. A method for deploying a modular endoluminal device in a deployment location in a branched lumen comprising a main lumen, a first branch lumen, and a second branch lumen, the modular endoluminal device comprising an outer member and an inner member, the outer member and inner member each comprising a stent-graft, a fluid inlet opening, a first fluid exit opening, and a second fluid exit opening, the device having an assembled configuration in which the inner member fits partially inside the outer member, the method comprising:
(a) inserting a first introducer containing the outer member into the branched lumen;
(b) deploying the outer member with the inlet opening in the main lumen, the first exit opening aligned with the first branch lumen, and the second exit opening positioned in the second branch lumen;
(c) inserting a second introducer containing the inner member into the branched lumen;
(d) assembling the device into the assembled configuration by deploying the inner member with the inner member inlet opening aligned with the outer member inlet opening, a portion of the inner member protruding through the outer member first exit opening and terminating at the inner member second exit opening, and the inner member first exit opening aligned with the outer member second exit opening; and
(e) the assembled device receiving endoluminal fluid from the main lumen through the aligned inner and outer member inlet openings and discharging the fluid into the first branch lumen through the inner member second exit opening and into the second branch lumen through the outer member second exit opening.
US11/385,621 2001-11-07 2006-03-21 Interlocking endoluminal device Abandoned US20060161245A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US11/385,621 US20060161245A1 (en) 2001-11-07 2006-03-21 Interlocking endoluminal device

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/010,628 US7029496B2 (en) 2001-11-07 2001-11-07 Interlocking endoluminal device
US11/385,621 US20060161245A1 (en) 2001-11-07 2006-03-21 Interlocking endoluminal device

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US10/010,628 Continuation US7029496B2 (en) 2001-11-07 2001-11-07 Interlocking endoluminal device

Publications (1)

Publication Number Publication Date
US20060161245A1 true US20060161245A1 (en) 2006-07-20

Family

ID=21746616

Family Applications (2)

Application Number Title Priority Date Filing Date
US10/010,628 Expired - Fee Related US7029496B2 (en) 2001-11-07 2001-11-07 Interlocking endoluminal device
US11/385,621 Abandoned US20060161245A1 (en) 2001-11-07 2006-03-21 Interlocking endoluminal device

Family Applications Before (1)

Application Number Title Priority Date Filing Date
US10/010,628 Expired - Fee Related US7029496B2 (en) 2001-11-07 2001-11-07 Interlocking endoluminal device

Country Status (7)

Country Link
US (2) US7029496B2 (en)
EP (1) EP1441782B1 (en)
AT (1) ATE430533T1 (en)
AU (1) AU2002363317A1 (en)
DE (1) DE60232263D1 (en)
ES (1) ES2326365T3 (en)
WO (1) WO2003039621A2 (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20150119975A1 (en) * 2013-10-24 2015-04-30 The Cleveland Clinic Foundation Branched vessel prosthesis for repair of a failed stent graft
US9132025B2 (en) 2012-06-15 2015-09-15 Trivascular, Inc. Bifurcated endovascular prosthesis having tethered contralateral leg
US9155612B2 (en) 2011-01-10 2015-10-13 Intermountain Invention Management, Llc Composite stent grafts for in situ assembly and related methods
US10159557B2 (en) 2007-10-04 2018-12-25 Trivascular, Inc. Modular vascular graft for low profile percutaneous delivery
US10470871B2 (en) 2001-12-20 2019-11-12 Trivascular, Inc. Advanced endovascular graft

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6660030B2 (en) 1998-12-11 2003-12-09 Endologix, Inc. Bifurcation graft deployment catheter
US8034100B2 (en) 1999-03-11 2011-10-11 Endologix, Inc. Graft deployment system
US6261316B1 (en) 1999-03-11 2001-07-17 Endologix, Inc. Single puncture bifurcation graft deployment system
US7267685B2 (en) * 2000-11-16 2007-09-11 Cordis Corporation Bilateral extension prosthesis and method of delivery
AU2002316254A1 (en) * 2001-06-18 2003-01-02 Eva Corporation Prosthetic graft assembly and method of use
US20050033416A1 (en) * 2003-05-02 2005-02-10 Jacques Seguin Vascular graft and deployment system
ATE389370T1 (en) * 2004-09-02 2008-04-15 Med Inst Inc MODULAR PROSTHESIS AND METHODS FOR BRANCH VESSELS
US9149355B2 (en) 2004-09-21 2015-10-06 Cook Medical Technologies Llc Side branch stent graft
JP2008518710A (en) * 2004-11-03 2008-06-05 セガン,ジャック Vascular graft and deployment system
US7616111B2 (en) * 2005-06-20 2009-11-10 Carestream Health, Inc. System to monitor the ingestion of medicines
US7782189B2 (en) * 2005-06-20 2010-08-24 Carestream Health, Inc. System to monitor the ingestion of medicines
US8523931B2 (en) 2007-01-12 2013-09-03 Endologix, Inc. Dual concentric guidewire and methods of bifurcated graft deployment
US8663309B2 (en) 2007-09-26 2014-03-04 Trivascular, Inc. Asymmetric stent apparatus and method
KR20090054493A (en) * 2007-11-27 2009-06-01 주식회사 에스앤지바이오텍 Cylindrical stent
US8221494B2 (en) * 2008-02-22 2012-07-17 Endologix, Inc. Apparatus and method of placement of a graft or graft system
US8236040B2 (en) 2008-04-11 2012-08-07 Endologix, Inc. Bifurcated graft deployment systems and methods
EP2293838B1 (en) 2008-07-01 2012-08-08 Endologix, Inc. Catheter system
EP2429452B1 (en) 2009-04-28 2020-01-15 Endologix, Inc. Endoluminal prosthesis system
WO2010127305A2 (en) 2009-05-01 2010-11-04 Endologix, Inc. Percutaneous method and device to treat dissections
US10772717B2 (en) 2009-05-01 2020-09-15 Endologix, Inc. Percutaneous method and device to treat dissections
US8491646B2 (en) 2009-07-15 2013-07-23 Endologix, Inc. Stent graft
EP2459127B1 (en) 2009-07-27 2015-09-23 Endologix, Inc. Stent graft
WO2011117736A2 (en) * 2010-03-22 2011-09-29 Scitech Produtos Medicos Ltda Endoprosthesis and delivery system for delivering the endoprosthesis within a vessel of a patient
US20120029611A1 (en) * 2010-07-28 2012-02-02 Medtronic Vascular, Inc. Stent Graft System and Method of Use
EP2635241B1 (en) 2010-11-02 2019-02-20 Endologix, Inc. Apparatus for placement of a graft or graft system
US9393100B2 (en) 2010-11-17 2016-07-19 Endologix, Inc. Devices and methods to treat vascular dissections
US8808350B2 (en) 2011-03-01 2014-08-19 Endologix, Inc. Catheter system and methods of using same
FR2975000B1 (en) * 2011-05-10 2013-06-14 Guro Bjoernstad VASCULAR ENDOPROSTHESIS
JP2018524025A (en) 2015-06-30 2018-08-30 エンドロジックス、インク Lock assembly for coupling guidewire to delivery system
US10772719B2 (en) * 2017-02-14 2020-09-15 Cook Medical Technologies Llc Method of making a contoured internal limb for a prosthesis and prosthesis with a contoured internal limb
EP3941392A1 (en) 2019-03-20 2022-01-26 Inqb8 Medical Technologies, LLC Aortic dissection implant

Citations (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5575818A (en) * 1995-02-14 1996-11-19 Corvita Corporation Endovascular stent with locking ring
US5609627A (en) * 1994-02-09 1997-03-11 Boston Scientific Technology, Inc. Method for delivering a bifurcated endoluminal prosthesis
US5683449A (en) * 1995-02-24 1997-11-04 Marcade; Jean Paul Modular bifurcated intraluminal grafts and methods for delivering and assembling same
US5693088A (en) * 1993-11-08 1997-12-02 Lazarus; Harrison M. Intraluminal vascular graft
US5755773A (en) * 1996-06-04 1998-05-26 Medtronic, Inc. Endoluminal prosthetic bifurcation shunt
US5824037A (en) * 1995-10-03 1998-10-20 Medtronic, Inc. Modular intraluminal prostheses construction and methods
US5961548A (en) * 1997-11-18 1999-10-05 Shmulewitz; Ascher Bifurcated two-part graft and methods of implantation
US6015431A (en) * 1996-12-23 2000-01-18 Prograft Medical, Inc. Endolumenal stent-graft with leak-resistant seal
US6017363A (en) * 1997-09-22 2000-01-25 Cordis Corporation Bifurcated axially flexible stent
US6019788A (en) * 1996-11-08 2000-02-01 Gore Enterprise Holdings, Inc. Vascular shunt graft and junction for same
US6077296A (en) * 1998-03-04 2000-06-20 Endologix, Inc. Endoluminal vascular prosthesis
US6102938A (en) * 1997-06-17 2000-08-15 Medtronic Inc. Endoluminal prosthetic bifurcation shunt
US6143002A (en) * 1998-08-04 2000-11-07 Scimed Life Systems, Inc. System for delivering stents to bifurcation lesions
US6165213A (en) * 1994-02-09 2000-12-26 Boston Scientific Technology, Inc. System and method for assembling an endoluminal prosthesis
US6193745B1 (en) * 1995-10-03 2001-02-27 Medtronic, Inc. Modular intraluminal prosteheses construction and methods
US6210429B1 (en) * 1996-11-04 2001-04-03 Advanced Stent Technologies, Inc. Extendible stent apparatus
US6302908B1 (en) * 1997-03-24 2001-10-16 Juan Carlos Parodi Arterial graft device and method of positioning the same
US20010037142A1 (en) * 2000-03-14 2001-11-01 Cook Incorporated Endovascular stent graft
US6325826B1 (en) * 1998-01-14 2001-12-04 Advanced Stent Technologies, Inc. Extendible stent apparatus
US6344052B1 (en) * 1999-09-27 2002-02-05 World Medical Manufacturing Corporation Tubular graft with monofilament fibers
US20020035389A1 (en) * 1996-05-03 2002-03-21 Jacob Richter Bifurcated stent with improved side branch aperture and method of making same
US6468301B1 (en) * 2000-03-27 2002-10-22 Aga Medical Corporation Repositionable and recapturable vascular stent/graft
US6811566B1 (en) * 1996-05-03 2004-11-02 Evysio Medical Devices Ulc Bifurcated stent and method for the manufacture of same

Patent Citations (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5693088A (en) * 1993-11-08 1997-12-02 Lazarus; Harrison M. Intraluminal vascular graft
US5609627A (en) * 1994-02-09 1997-03-11 Boston Scientific Technology, Inc. Method for delivering a bifurcated endoluminal prosthesis
US5683450A (en) * 1994-02-09 1997-11-04 Boston Scientific Technology, Inc. Bifurcated endoluminal prosthesis
US6165213A (en) * 1994-02-09 2000-12-26 Boston Scientific Technology, Inc. System and method for assembling an endoluminal prosthesis
US5575818A (en) * 1995-02-14 1996-11-19 Corvita Corporation Endovascular stent with locking ring
US5993481A (en) * 1995-02-24 1999-11-30 Intervascular, Inc. Modular bifurcated intraluminal grafts and methods for delivering and assembling same
US5683449A (en) * 1995-02-24 1997-11-04 Marcade; Jean Paul Modular bifurcated intraluminal grafts and methods for delivering and assembling same
US5824037A (en) * 1995-10-03 1998-10-20 Medtronic, Inc. Modular intraluminal prostheses construction and methods
US6193745B1 (en) * 1995-10-03 2001-02-27 Medtronic, Inc. Modular intraluminal prosteheses construction and methods
US6811566B1 (en) * 1996-05-03 2004-11-02 Evysio Medical Devices Ulc Bifurcated stent and method for the manufacture of same
US20020035389A1 (en) * 1996-05-03 2002-03-21 Jacob Richter Bifurcated stent with improved side branch aperture and method of making same
US5755773A (en) * 1996-06-04 1998-05-26 Medtronic, Inc. Endoluminal prosthetic bifurcation shunt
US6210429B1 (en) * 1996-11-04 2001-04-03 Advanced Stent Technologies, Inc. Extendible stent apparatus
US6019788A (en) * 1996-11-08 2000-02-01 Gore Enterprise Holdings, Inc. Vascular shunt graft and junction for same
US6015431A (en) * 1996-12-23 2000-01-18 Prograft Medical, Inc. Endolumenal stent-graft with leak-resistant seal
US6302908B1 (en) * 1997-03-24 2001-10-16 Juan Carlos Parodi Arterial graft device and method of positioning the same
US6102938A (en) * 1997-06-17 2000-08-15 Medtronic Inc. Endoluminal prosthetic bifurcation shunt
US6017363A (en) * 1997-09-22 2000-01-25 Cordis Corporation Bifurcated axially flexible stent
US5961548A (en) * 1997-11-18 1999-10-05 Shmulewitz; Ascher Bifurcated two-part graft and methods of implantation
US6325826B1 (en) * 1998-01-14 2001-12-04 Advanced Stent Technologies, Inc. Extendible stent apparatus
US6077296A (en) * 1998-03-04 2000-06-20 Endologix, Inc. Endoluminal vascular prosthesis
US6143002A (en) * 1998-08-04 2000-11-07 Scimed Life Systems, Inc. System for delivering stents to bifurcation lesions
US6344052B1 (en) * 1999-09-27 2002-02-05 World Medical Manufacturing Corporation Tubular graft with monofilament fibers
US20010037142A1 (en) * 2000-03-14 2001-11-01 Cook Incorporated Endovascular stent graft
US6468301B1 (en) * 2000-03-27 2002-10-22 Aga Medical Corporation Repositionable and recapturable vascular stent/graft

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10470871B2 (en) 2001-12-20 2019-11-12 Trivascular, Inc. Advanced endovascular graft
US11439497B2 (en) 2001-12-20 2022-09-13 Trivascular, Inc. Advanced endovascular graft
US10159557B2 (en) 2007-10-04 2018-12-25 Trivascular, Inc. Modular vascular graft for low profile percutaneous delivery
US10682222B2 (en) 2007-10-04 2020-06-16 Trivascular, Inc. Modular vascular graft for low profile percutaneous delivery
US9155612B2 (en) 2011-01-10 2015-10-13 Intermountain Invention Management, Llc Composite stent grafts for in situ assembly and related methods
US9132025B2 (en) 2012-06-15 2015-09-15 Trivascular, Inc. Bifurcated endovascular prosthesis having tethered contralateral leg
US10195060B2 (en) 2012-06-15 2019-02-05 Trivascular, Inc. Bifurcated endovascular prosthesis having tethered contralateral leg
US11000390B2 (en) 2012-06-15 2021-05-11 Trivascular, Inc. Bifurcated endovascular prosthesis having tethered contralateral leg
US11779479B2 (en) 2012-06-15 2023-10-10 Trivascular, Inc. Bifurcated endovascular prosthesis having tethered contralateral leg
US20150119975A1 (en) * 2013-10-24 2015-04-30 The Cleveland Clinic Foundation Branched vessel prosthesis for repair of a failed stent graft

Also Published As

Publication number Publication date
EP1441782A2 (en) 2004-08-04
WO2003039621A9 (en) 2003-12-18
DE60232263D1 (en) 2009-06-18
ES2326365T3 (en) 2009-10-08
WO2003039621A3 (en) 2003-11-20
EP1441782B1 (en) 2009-05-06
AU2002363317A1 (en) 2003-05-19
US20030088306A1 (en) 2003-05-08
US7029496B2 (en) 2006-04-18
WO2003039621A2 (en) 2003-05-15
ATE430533T1 (en) 2009-05-15

Similar Documents

Publication Publication Date Title
US7029496B2 (en) Interlocking endoluminal device
US9078780B2 (en) Balloon flareable branch vessel prosthesis and method
EP1915106B1 (en) Method of manufacturing fenestrated stent grafts
US8197533B2 (en) Stent with segmented graft
EP1325716B1 (en) Thoracic aneurysm repair prosthesis and system
JP4291971B2 (en) Modified guidewire access modulator endoluminal prosthesis with connections
EP1325717B1 (en) Stent graft with branch leg
US8257430B2 (en) Interconnected leg extensions for an endoluminal prosthesis
EP1009325B1 (en) Bifurcated vascular graft and method and apparatus for deploying same
AU738826B2 (en) Endovascular prosthetic device, and method of use
US6951572B1 (en) Bifurcated vascular graft and method and apparatus for deploying same
US20030130725A1 (en) Sealing prosthesis
US20110218617A1 (en) Endoluminal vascular prosthesis
WO1998004212A1 (en) Two-piece, bifurcated intraluminal graft for repair of aneurysm
US9687366B2 (en) Endoleak mitigator for aneurysm stent-graft

Legal Events

Date Code Title Description
AS Assignment

Owner name: ACACIA RESEARCH GROUP LLC, TEXAS

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:BOSTON SCIENTIFIC SCIMED, INC.;REEL/FRAME:030694/0461

Effective date: 20121220

STCB Information on status: application discontinuation

Free format text: ABANDONED -- AFTER EXAMINER'S ANSWER OR BOARD OF APPEALS DECISION

AS Assignment

Owner name: LIFESHIELD SCIENCES LLC, TEXAS

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:ACACIA RESEARCH GROUP LLC;REEL/FRAME:030740/0225

Effective date: 20130515